330 related articles for article (PubMed ID: 14985923)
1. The activity of pramipexole in the mouse forced swim test is mediated by D2 rather than D3 receptors.
Siuciak JA; Fujiwara RA
Psychopharmacology (Berl); 2004 Sep; 175(2):163-9. PubMed ID: 14985923
[TBL] [Abstract][Full Text] [Related]
2. Dopamine D2/D3 but not dopamine D1 receptors are involved in the rapid antidepressant-like effects of ketamine in the forced swim test.
Li Y; Zhu ZR; Ou BC; Wang YQ; Tan ZB; Deng CM; Gao YY; Tang M; So JH; Mu YL; Zhang LQ
Behav Brain Res; 2015 Feb; 279():100-5. PubMed ID: 25449845
[TBL] [Abstract][Full Text] [Related]
3. Effects of pramipexole on the duration of immobility during the forced swim test in normal and ACTH-treated rats.
Kitagawa K; Kitamura Y; Miyazaki T; Miyaoka J; Kawasaki H; Asanuma M; Sendo T; Gomita Y
Naunyn Schmiedebergs Arch Pharmacol; 2009 Jul; 380(1):59-66. PubMed ID: 19274453
[TBL] [Abstract][Full Text] [Related]
4. The behavioural effects of pramipexole, a novel dopamine receptor agonist.
Maj J; Rogóz Z; Skuza G; Kołodziejczyk K
Eur J Pharmacol; 1997 Apr; 324(1):31-7. PubMed ID: 9137910
[TBL] [Abstract][Full Text] [Related]
5. Effects of the D3 preferring dopamine agonist pramipexole on sleep and waking, locomotor activity and striatal dopamine release in rats.
Lagos P; Scorza C; Monti JM; Jantos H; Reyes-Parada M; Silveira R; Ponzoni A
Eur Neuropsychopharmacol; 1998 May; 8(2):113-20. PubMed ID: 9619689
[TBL] [Abstract][Full Text] [Related]
6. Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors.
Brocco M; Dekeyne A; Papp M; Millan MJ
Behav Pharmacol; 2006 Nov; 17(7):559-72. PubMed ID: 17021388
[TBL] [Abstract][Full Text] [Related]
7. Excitation of type II anterior caudate neurons by stimulation of dopamine D3 receptors.
Piercey MF; Hyslop DK; Hoffmann WE
Brain Res; 1997 Jul; 762(1-2):19-28. PubMed ID: 9262154
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of synergistic action following co-treatment with pramipexole and fluoxetine or sertraline in the forced swimming test in rats.
Rogóz Z; Skuza G
Pharmacol Rep; 2006; 58(4):493-500. PubMed ID: 16963794
[TBL] [Abstract][Full Text] [Related]
9. Antidepressant effects of pramipexole, a novel dopamine receptor agonist.
Maj J; Rogóz Z; Skuza G; Kołodziejczyk K
J Neural Transm (Vienna); 1997; 104(4-5):525-33. PubMed ID: 9295183
[TBL] [Abstract][Full Text] [Related]
10. Food restriction alters N'-propyl-4,5,6,7-tetrahydrobenzothiazole-2,6-diamine dihydrochloride (pramipexole)-induced yawning, hypothermia, and locomotor activity in rats: evidence for sensitization of dopamine D2 receptor-mediated effects.
Collins GT; Calinski DM; Newman AH; Grundt P; Woods JH
J Pharmacol Exp Ther; 2008 May; 325(2):691-7. PubMed ID: 18305018
[TBL] [Abstract][Full Text] [Related]
11. Antidepressant-like effect of D(2/3) receptor-, but not D(4) receptor-activation in the rat forced swim test.
Basso AM; Gallagher KB; Bratcher NA; Brioni JD; Moreland RB; Hsieh GC; Drescher K; Fox GB; Decker MW; Rueter LE
Neuropsychopharmacology; 2005 Jul; 30(7):1257-68. PubMed ID: 15688083
[TBL] [Abstract][Full Text] [Related]
12. Antidepressant effect of pramipexole in mice forced swimming test: A cross talk between dopamine receptor and NMDA/nitric oxide/cGMP pathway.
Ostadhadi S; Imran Khan M; Norouzi-Javidan A; Dehpour AR
Biomed Pharmacother; 2016 Jul; 81():295-304. PubMed ID: 27261607
[TBL] [Abstract][Full Text] [Related]
13. Pramipexole inhibits MPTP toxicity in mice by dopamine D3 receptor dependent and independent mechanisms.
Ramirez AD; Wong SK; Menniti FS
Eur J Pharmacol; 2003 Aug; 475(1-3):29-35. PubMed ID: 12954356
[TBL] [Abstract][Full Text] [Related]
14. Locomotor hypoactivity and motor disturbances--behavioral effects induced by intracerebellar microinjections of dopaminergic DA-D2/D3 receptor agonists.
Kolasiewicz W; Maj J
Pol J Pharmacol; 2001; 53(5):509-15. PubMed ID: 11990070
[TBL] [Abstract][Full Text] [Related]
15. Proerectile effects of dopamine D2-like agonists are mediated by the D3 receptor in rats and mice.
Collins GT; Truccone A; Haji-Abdi F; Newman AH; Grundt P; Rice KC; Husbands SM; Greedy BM; Enguehard-Gueiffier C; Gueiffier A; Chen J; Wang S; Katz JL; Grandy DK; Sunahara RK; Woods JH
J Pharmacol Exp Ther; 2009 Apr; 329(1):210-7. PubMed ID: 19136638
[TBL] [Abstract][Full Text] [Related]
16. Involvement of dopamine (DA)/serotonin (5-HT)/sigma (sigma) receptor modulation in mediating the antidepressant action of ropinirole hydrochloride, a D2/D3 dopamine receptor agonist.
Dhir A; Kulkarni SK
Brain Res Bull; 2007 Sep; 74(1-3):58-65. PubMed ID: 17683790
[TBL] [Abstract][Full Text] [Related]
17. Decreased locomotor activity after microinjection of dopamine D2/D3 receptor agonists and antagonists into lobule 9/10 of the cerebellum: a D3 receptor mediated effect?
Boulay D; Depoortere R; Perrault G; Sanger DJ
Prog Neuropsychopharmacol Biol Psychiatry; 2000 Jan; 24(1):39-49. PubMed ID: 10659982
[TBL] [Abstract][Full Text] [Related]
18. The effect of repeated treatment with pramipexole on the central dopamine D3 system.
Maj J; Rogói Z; Margas W; Kata M; Dziedzicka-Wasylewska M
J Neural Transm (Vienna); 2000; 107(12):1369-79. PubMed ID: 11458990
[TBL] [Abstract][Full Text] [Related]
19. Dopamine D3 receptor agonists produce similar decreases in body temperature and locomotor activity in D3 knock-out and wild-type mice.
Boulay D; Depoortere R; Rostene W; Perrault G; Sanger DJ
Neuropharmacology; 1999 Apr; 38(4):555-65. PubMed ID: 10221759
[TBL] [Abstract][Full Text] [Related]
20. The discriminative stimulus effects of dopamine D2- and D3-preferring agonists in rats.
Koffarnus MN; Greedy B; Husbands SM; Grundt P; Newman AH; Woods JH
Psychopharmacology (Berl); 2009 Apr; 203(2):317-27. PubMed ID: 18807248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
